India’s Contract Development and Manufacturing Organization (CDMO) market is witnessing a strong growth trajectory driven by ...

Traditional approaches to benchmarking brand performance have struggled to keep pace with industry dynamics. While individual ...

Treatments for autoimmune diseases and those in orphan markets are on the up and up, as are drugmakers’ first launches, ...

Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.

and to establish if there was broad uniformity in how market access was defined and developed. There were 104 responders, comprised of 50% from pharma, 41% from agencies and the remainder from ...

As blockchain expands its reach across different industries, Gunjan Bhardwaj examines some of its practical applications in the pharma industry. Blockchain is quickly increasing in interest and ...

The role of AI in supply chain management proved to be the focal issue at the recent 2025 Clinical Trial Supply Europe ...

In today’s clinical trials, compared to those of the past, there is increasing complexity, greater data collection, and a ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Inozyme Pharma (INZY – Research Report) and ...

Warning that the state’s health care system is “falling apart,” the Senate’s point person on the topic said Thursday that she wants to rein in for-profit and private equity entities as well as give ...

India ranked 11th in global pharmaceutical exports in 2023, contributing 3%, while regulators have intensified quality checks, inspected 905 units, and taken 694 enforcement actions since December ...